Estimating the impact of drug use on US mortality, 1999-2016.

The impact of rising drug use on US mortality may extend beyond deaths coded as drug-related to include excess mortality from other causes affected by drug use. Here, we estimate the full extent of drug-associated mortality. We use annual death rates for 1999-2016 by state, sex, five-year age group,...

Full description

Bibliographic Details
Main Authors: Dana A Glei, Samuel H Preston
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0226732
id doaj-5b3ed6ab7845488c89ef7e66281e4db3
record_format Article
spelling doaj-5b3ed6ab7845488c89ef7e66281e4db32021-06-19T05:09:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01151e022673210.1371/journal.pone.0226732Estimating the impact of drug use on US mortality, 1999-2016.Dana A GleiSamuel H PrestonThe impact of rising drug use on US mortality may extend beyond deaths coded as drug-related to include excess mortality from other causes affected by drug use. Here, we estimate the full extent of drug-associated mortality. We use annual death rates for 1999-2016 by state, sex, five-year age group, and cause of death to model the relationship between drug-coded mortality-which serves as an indicator of the population-level prevalence of drug use-and mortality from other causes. Among residents aged 15-64 living in the 50 US states, the estimated number of drug-associated deaths in 2016 (141,695) was 2.2 times the number of drug-coded deaths (63,000). Adverse trends since 2010 in midlife mortality are largely attributable to drug-associated mortality. In the absence of drug use, we estimate that the probability of dying between ages 15 and 65 would have continued to decline after 2010 among men (to 15% in 2016) and would have remained at a low level (10%) among women. Our results suggest that an additional 3.9% of men and 1.8% of women died between ages 15 and 65 in 2016 because of drug use. In terms of life expectancy beyond age 15, we estimate that drug use cost men 1.4 years and women 0.7 years, on average. In the hardest-hit state (West Virginia), drug use cost men 3.6 and women 1.9 life years. Recent declines in US life expectancy have been blamed largely on the drug epidemic. Consistent with that inference, our results imply that, in the absence of drug use, life expectancy at age 15 would have increased slightly between 2014 and 2016. Drug-associated mortality in the US is roughly double that implied by drug-coded deaths alone. The drug epidemic is exacting a heavy cost to American lives, not only from overdoses but from a variety of causes.https://doi.org/10.1371/journal.pone.0226732
collection DOAJ
language English
format Article
sources DOAJ
author Dana A Glei
Samuel H Preston
spellingShingle Dana A Glei
Samuel H Preston
Estimating the impact of drug use on US mortality, 1999-2016.
PLoS ONE
author_facet Dana A Glei
Samuel H Preston
author_sort Dana A Glei
title Estimating the impact of drug use on US mortality, 1999-2016.
title_short Estimating the impact of drug use on US mortality, 1999-2016.
title_full Estimating the impact of drug use on US mortality, 1999-2016.
title_fullStr Estimating the impact of drug use on US mortality, 1999-2016.
title_full_unstemmed Estimating the impact of drug use on US mortality, 1999-2016.
title_sort estimating the impact of drug use on us mortality, 1999-2016.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description The impact of rising drug use on US mortality may extend beyond deaths coded as drug-related to include excess mortality from other causes affected by drug use. Here, we estimate the full extent of drug-associated mortality. We use annual death rates for 1999-2016 by state, sex, five-year age group, and cause of death to model the relationship between drug-coded mortality-which serves as an indicator of the population-level prevalence of drug use-and mortality from other causes. Among residents aged 15-64 living in the 50 US states, the estimated number of drug-associated deaths in 2016 (141,695) was 2.2 times the number of drug-coded deaths (63,000). Adverse trends since 2010 in midlife mortality are largely attributable to drug-associated mortality. In the absence of drug use, we estimate that the probability of dying between ages 15 and 65 would have continued to decline after 2010 among men (to 15% in 2016) and would have remained at a low level (10%) among women. Our results suggest that an additional 3.9% of men and 1.8% of women died between ages 15 and 65 in 2016 because of drug use. In terms of life expectancy beyond age 15, we estimate that drug use cost men 1.4 years and women 0.7 years, on average. In the hardest-hit state (West Virginia), drug use cost men 3.6 and women 1.9 life years. Recent declines in US life expectancy have been blamed largely on the drug epidemic. Consistent with that inference, our results imply that, in the absence of drug use, life expectancy at age 15 would have increased slightly between 2014 and 2016. Drug-associated mortality in the US is roughly double that implied by drug-coded deaths alone. The drug epidemic is exacting a heavy cost to American lives, not only from overdoses but from a variety of causes.
url https://doi.org/10.1371/journal.pone.0226732
work_keys_str_mv AT danaaglei estimatingtheimpactofdruguseonusmortality19992016
AT samuelhpreston estimatingtheimpactofdruguseonusmortality19992016
_version_ 1721371366036340736